Upcoming

Mark Foundation Endeavor Awards 2025

Limit: 2* // Tickets Available: 0

K. Huntoon (Neurosurgery)

J. Farr (Medicine - COM-T)

*The first submission may address any cancer type. A second submission is allowed but only for a translational or clinical stage project that primarily focuses on one of the following four cancer types: upper GI, glioblastoma, triple-negative breast cancer, or pancreatic cancer.

The University of Arizona Cancer Center (UACC) is coordinating this limited submission. For more information please contact: UACC-PreAward.

Purpose of the Award
The Mark Foundation Endeavor Awards support collaborative research projects that bring together investigators with diverse areas of expertise to tackle challenges in the prevention, diagnosis, and treatment of cancer. These grants are awarded to teams of three or more investigators to generate and integrate data from diverse lines of research and transform those insights into advances for cancer patients that could not be achieved by individual efforts. Basic, translational, and clinical projects are eligible. The project must seek to address an overarching, urgent scientific question. We welcome projects addressing substantial unmet needs in any type of cancer. We particularly encourage teams with innovative ideas for therapeutic strategies for upper GI, glioblastoma, triple-negative breast cancer, and pancreatic cancer to consider applying in this round.

Funding Type
Internal Deadline
External Deadline
9/3/2025
Solicitation Type

V Foundation V Scholar Cancer Research Award 2025

Limit: 1 // Tickets Available: 0

K. Huntoon (Neurosurgery)

For the V Foundation V Scholar Grant 2025 funding opportunity, the University of Arizona Cancer Center (UACC) can nominate one applicant.

For more information please contact: UACC-PreAward.

Purpose of Award:

The UACC is seeking nominations for the V Scholar Grant call which supports adult cancer research. This award supports tenure-track faculty early in their cancer research career by funding projects that are either laboratory-based fundamental research or translational research. Emphasis for this grant mechanism is on supporting exceptional early career investigators at the Assistant Professor stage to be better positioned to leverage large R01 or similar sustaining grants.

Research on ANY adult cancer type will be funded in this call. Research areas not included in this scope are epidemiology, behavioral science, and health services research.

Applicant Eligibility:

Nominee must meet all of the following criteria by the nomination due date:

  • Nominated by their Cancer Center Director or similar high ranking research official.
  • Employed at a non-profit research institution (e.g., 501c3, Section 170).
  • Either a US Citizen or a permanent legal resident in the US.
  • Possess at least 2 years post-doctoral (MD or PhD) fellowship training. For MDs, a minimum of one year is acceptable if only one year is required for their specialty.
  • Clinical scientists are eligible if the research institution demonstrates that it will fully support the research applicant (e.g., dedicated lab space, committed research time, start-up funds).
  • Must be in a full-time tenure track or tenured faculty position (for e.g., must be eligible to
    apply for PI status on an R01 at your institution). Non-promotable adjunct, affiliated, temporary, part-time, or acting faculty positions are not eligible for Principal Investigator nomination.
  • V Scholar applicants must have been appointed to their first full-time tenure track Assistant Professor position no more than 5 years prior to the nomination due date, and not yet promoted to Associate Professor.
    • Extensions to the 5-year limit may be given on a case-by-case basis to nominees who took parental leave (or other types of leave) during this window. Please contact grants@v.org with the following to obtain approval BEFORE submitting the nomination form:
      • Appointment start date
      • Length of leave
      • Institutional tenure clock stoppages/extensions, if applicable
Funding Type
Internal Deadline
External Deadline
6/2/2025
Sponsor
Solicitation Type